Clinical Trial: Bank of Human Leukocytes From COVID-19 Convalescent Donors With an Anti-SARS-CoV-2 Cellular Immunity
Study Status: Completed
Recruit Status: RECRUITING
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: Human Leucocytes Bank From COVID-19 Cured Patients With a Cellular Immunity Against SARS-CoV-2 :Raw Material for the Preparation of an Anti-SARS-CoV-2 Cellular Immunotherapy
Brief Summary:
The SARS-CoV-2 identified in China in January 2020 is the cause of an unprecedented pandemic.The SARS-CoV-2 and each viral variant are responsible of a respiratory infectious disease, which can be asymptomatic.Nevertheless, a part of infected patients will experiment serious forms associated with a high mortality rate.Most serious forms present with lymphopenia and a functional exhaustion of speicifci T lymphocytes.Several studies showed that these quantitative and qualitative lymphocyte abnormalities are…
Read more